Spring Bank Pharmaceuticals, Inc. (SBPH)

Trade SBPH now with
7/29/2019 8:20:12 AM Spring Bank Says FDA Acceptance Of IND For SB 11285 For Advanced Solid Tumors
7/10/2019 4:15:24 PM Spring Bank Pharmaceuticals Elects Pamela Klein To Its Board Of Directors
6/27/2019 8:49:01 AM Spring Bank To Present Pre-clinical Data From STING Antagonist Program
12/18/2018 4:24:44 PM Spring Bank Pharmaceuticals Appoints Scott Smith As Chairman Of Board
11/29/2018 8:08:21 AM Spring Bank Announces Additional Pre-Clinical Data On Its Second-Generation STING Agonist Program
8/8/2018 9:49:39 PM Spring Bank Pharma Announces Pricing Of Underwritten Public Offering Of 3 Mln Shares At $12.50/shr
4/27/2018 8:13:46 AM Spring Bank Pharma Q1 Net Loss $4.9 Mln Or $0.37/Shr Vs $6.5 Mln Or $0.69/Shr Last Year
4/10/2018 8:34:37 AM Spring Bank Announces Expanded Inarigivir Data From ACHIEVE Trial To Be Presented At EASL
3/5/2018 4:04:05 PM Spring Bank Pharmaceuticals Appoints Timothy Clackson To Its Board Of Directors
11/6/2017 9:17:58 AM B. Riley FBR Initiates Spring Bank Pharmaceuticals, Inc. (SBPH) At Buy With $30 Price Target